Abstract

These findings indicate that immunity against the delta variant of SARS-CoV-2 waned in all age groups a few months after receipt of the second dose of vaccine.

Affiliated Institutions

Related Publications

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Eric J. Haas , Frederick J. Angulo , John M. McLaughlin +12 more

Following the emergency use authorisation of the Pfizer-BioNTech mRNA COVID-19 vaccine BNT162b2 (international non-proprietary name tozinameran) in Israel, the Ministry of Healt...

2021 The Lancet 1722 citations

Publication Info

Year
2021
Type
article
Volume
385
Issue
24
Pages
e85-e85
Citations
1025
Access
Closed

External Links

View on DOI.org

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1025
OpenAlex

Cite This

Yair Goldberg, Micha Mandel, Yinon M Bar-On et al. (2021). Waning Immunity after the BNT162b2 Vaccine in Israel. New England Journal of Medicine , 385 (24) , e85-e85. https://doi.org/10.1056/nejmoa2114228

Identifiers

DOI
10.1056/nejmoa2114228